To explore the scope and significance of alternate promoter usage and its putative inter-relationship to alternative splicing, we searched expression sequence tags for the 5 region of acetylcholinesterase (ACHE) genes. Three and five novel first exons were identified in human and mouse ACHE genes, respectively. Reverse transcription-PCR and in situ hybridization validated most of the predicted transcripts, and sequence analyses of the corresponding genomic DNA regions suggest evolutionarily conserved promoters for each of the novel exons identified. Distinct tissue specificity and stress-related expression patterns of these exons predict combinatorial complexity with known 3 alternative AChE mRNA transcripts. Unexpectedly one of the 5 exons encodes an extended N terminus in-frame with the known AChE sequence, extending the increased complexity to the protein level. The resultant membrane variant(s), designated N-AChE, is developmentally regulated in human brain neurons and blood mononuclear cells. Alternative promoter usage combined with alternative splicing may thus lead to stress-dependent combinatorial complexity of AChE mRNA transcripts and their protein products.
Alternative splicing and alternate promoter usage both expand the complexity of gene products. While the massive contribution of alternative splicing to such expansion is widely recognized (1), less is known about the scope and significance of alternate promoter usage. Moreover the directionality of transcription processes raises the yet unresolved possibility that these two phenomena are inter-related, namely that the choice of the first exon determines downstream splice choices (2) . The recent accumulation of genomic and gene expression data bases together with the development of sophisticated bioinformatic tools makes these questions amenable for experimental analysis as multiple gene products display both alternate promoter usage and alternative splicing variations. By alignment of expression sequence tags (ESTs) 1 against genomic sequences, for example, it is possible to explore the different alternatively spliced products of a single gene (3, 4) . However, EST data bases are biased toward the 3Ј end of mRNAs and occasionally contain genomic contaminations that may cause misinterpretation of the genomic information (5) . To correctly evaluate the inter-relationship between alternate promoter usage and alternative splicing, it is therefore necessary to characterize the identified variants using traditional molecular biology tools at the RNA level and, if applicable, at the protein level as well.
The acetylcholine-hydrolyzing enzyme acetylcholinesterase (AChE) provides an adequate example for such a study. AChE pre-mRNA is subject to stimulus-induced 3Ј alternative splicing (6) , and previous evidence has suggested that it is also subject to alternate promoter usage (7, 8) . We analyzed the genomic regions flanking the human and mouse ACHE genes and found an unexpected, evolutionarily conserved diversity of alternate exons at their 5Ј end. The newly identified exons are stress-and glucocorticoid-regulated and show no apparent connection to the 3Ј splice variations. One of these new exons was further found to initiate an N-terminal extension to the canonic AChE protein, enabling a combinatorial complexity of developmentally controlled human membrane AChE protein variant(s). Our findings highlight independent yet inter-related expansions of ACHE gene products by 5Ј and 3Ј variations in AChE mRNA.
EXPERIMENTAL PROCEDURES
Human Tissues-The use of human embryos, cord blood, and adult tissues in this study was approved by the Tel-Aviv Sourasky Medical Center Ethics Committee according to the regulations of the Helsinki accords. Tissue samples from spontaneously aborted human fetuses at different ages (16, 25 , and 34 gestational weeks) were transferred immediately to 4% paraformaldehyde, embedded in paraffin, and sliced (7 m). Fresh samples of umbilical cord blood cells were obtained following normal deliveries. Adult human brain samples were collected within 4 h postmortem from a 70-year-old patient with cardiac arrhythmia. Tissues were frozen immediately in liquid nitrogen. Brain homogenates (in 0.1 M phosphate buffer, 1% Triton X-100) were immunoblotted using standard procedures.
Animals-Central nervous system-specific glucocorticoid receptor (GR) mutants (GR NesCre ), control littermates (GR LoxP/LoxP ) (9) , and FVB/N male mice were kept under a 12-h dark/12-h light diurnal schedule with food and water ad libitum. Stress experiments included a 30-min immobilization in 50-ml conical tubes. Mice were sacrificed by decapitation 2 h after immobilization, and brains were dissected on ice, frozen in liquid nitrogen or fixed in 4% paraformaldehyde for 24 h, embedded in paraffin, sliced to 5-7-m sections, and collected by adhesion to Superfrost®-Plus slides (Menzel-Glaser, Braunschweig, Germany). For all experiments, naïve age-matched males served as controls. These experiments were approved by the animal committee in the Hebrew University.
Computational Resources-The human (GenBank TM accession number AF002993) and mouse (GenBank TM accession number AF312033) ACHE loci were analyzed using the National Center for Biotechnology Information for access to the GenBank TM as well as to Blast, Entrez, Locus Link, Structure, Protein, and OMIM (Online Mendelian Inheritance in Man) data base resources. Expert Protein Analysis System at the Swiss Institute of Bioinformatics was used for access to a variety of data manipulation programs and protein data bases. The Baylor College of Medicine Search Launcher 2 served for data manipulation and to derive display programs. The MatInspector program at Genomatix or the Cister software 3 was used to find transcription factor binding sites. RNA Extraction and cDNA Preparation-Total RNA was extracted from animal and human tissues using the EZ-RNA total RNA isolation kit (Biological Industries, Beit Haemek, Israel) as instructed, diluted in diethyl pyrocarbonate-treated water to a concentration of 100 ng/l, and stored at Ϫ70°C until use. Human RNA from leukemic T-lymphocytes, liver, and testis was obtained from Ambion (Austin, TX). SuperScript reverse transcriptase (Invitrogen) was used with either poly(dT) or random hexamers. Gene-specific primers (see below) were used for one-step RT-PCR (Qiagen, Hilden, Germany).
Fluorescence in Situ Hybridization (FISH)-Paraffin-embedded sections (mouse horizontal whole brain sections or human sagittal sections from whole embryos or human adult prefrontal cortex) were subjected to deparaffination with xylene (two 5-min washes) followed by decreasing ethanol washes (100, 75, 50, and 25%) and then a wash in phosphate-buffered saline with 0.5% Tween 20 and incubation with 10 mg/ml proteinase K (8 min at room temperature). Hybridization in a humidified chamber involved 10 mg/ml probe (in 50% formamide, 5ϫ SSC, 10 mg/ml tRNA, 10 mg/ml heparin for 90 min at 52°C). Sections were then washed twice at 60°C with 50% formamide, 5ϫ SSC, and 0.5% SDS; twice in 50% formamide, 2ϫ SSC at 60°C; and twice in Tris-buffered saline ϩ 0.1% Tween 20 (TBST) at room temperature and then blocked in 1% skim milk (Bio-Rad) for 30 min.
Biotin-labeled probes (see Supplemental Table I ) were detected by incubating sections with streptavidin-Cy3 conjugates (CyDye TM , Amersham Biosciences) for 30 min followed by three washes in TBST. Sections were mounted with IMMU-MOUNT (Shandon Inc., Pittsburgh, PA).
Polymerase Chain Reaction-PCR was used for detecting different transcripts in various tissues and to confirm sequences. The PCR mixture contained 2 units of Taq DNA polymerase (Sigma), deoxynucleotide mixture (0.2 mM each) (Sigma), forward/reverse primers (see Supplemental Table II , 0.5 M each), and 300 ng of template (cDNA or genomic DNA). Each of the 35 cycles included denaturation (1 min at 95°C), annealing (1 min at 60°C), and elongation (72°C at 1 min).
Antibodies-High affinity polyclonal rabbit IgG antibodies against the human hE1d-encoded N-terminal domain were custom-made (Eurogentec, Seraing, Belgium). Two 16-amino acid residue peptides from the coding sequence of human exon hE1d (hN-AChE) were synthesized (KVRSHPSGNQHRPTRG and GSRSFHCRRGVRPRPA), mixed, and injected together into two rabbits. Additional boost injections were given at 2, 4, and 8 weeks thereafter. Final bleeding was carried out after week 16. Enzyme-linked immunosorbent assay screening with the synthetic peptides served to identify successful antibody production. The synthetic peptides were further used for affinity purification of the antibodies. Dilutions of 1:500 of the affinity-purified antiserum were used for Western blotting.
Flow Cytometry-Mononuclear fractions of cord blood cells were separated by FACS lysing solution (BD Biosciences, diluted 1:100 in double-distilled water, 12-min incubation). Cells were either stained directly with phycoerythrin-conjugated CD34 (BD Biosciences), allophycocyanine-conjugated CD3 (Caltag, Burlingame, CA), allophycocyanine-conjugated CD19 (BD Biosciences), peridinin chlorophyll protein-conjugated CD45 (BD Biosciences), and phycoerythrin-conjugated interleukin 7 (R&D Systems Inc., Minneapolis, MN) antibodies or first permeabilized and fixed (Fix and Perm kit, Caltag; 7 min) and then stained. Isotype controls served to distinguish unspecific labeling. Rabbit anti-hN-AChE antibodies were detected on these cells using fluorescein isothiocyanate-conjugated goat anti-rabbit Fab antibodies (Jackson Immunoresearch Laboratories, Inc., Westgrove, PA). Multiparameter flow cytometry was performed using the FACScalibur flow cytometry system (BD Biosciences) equipped with Cellquest software (BD Biosciences). hN-AChE expression was assessed in fresh CD45 ϩ cells by analyzing 50,000 gated events.
RESULTS

5Ј
Diversity of Murine AChE mRNAs-EST data base searches using the 5Ј region of the mouse (m) ACHE gene revealed the existence of five putative alternative first exons (Table I and Fig. 1A ). The most proximal exon was termed mE1a. The EST clone containing this sequence (GenBank TM accession number BB606349, mouse eyeball) extends from position Ϫ787 to Ϫ680 (relative to the translational ATG start present in the mouse exon 2) and continues with exon 2 (Fig. 1,  A and B) , skipping over a 657-nucleotide (nt) intron (termed mouse mI1a) that possesses consensus GT-AG splice sites. RT-PCR and sequencing confirmed the existence of this transcript in the mouse cortex (GenBank TM deposit, accession number AY389982).
A second first exon, named mE1b, was found by RT-PCR using a forward primer located in the Ϫ945 to Ϫ923 region with a reverse primer on exon 2 (see Supplemental Table II ). The resulting product extends from this primer to position Ϫ733 and skips over a 710-nt intron (mI1b), which includes consensus GT-AG splice sites (Fig. 1, A and B) . This exon as well was confirmed in the mouse cortex by RT-PCR and sequencing (GenBank TM deposit, accession number AY389981). Upstream to mE1b, at Ϫ1762 to Ϫ1671, we found the "clas- 2 See searchlauncher.bcm.tmc.edu. 3 See zlab.bu.edu/ϳmfrith/cister.shtml. sical" exon 1 (10), renamed here mE1c, in 18 different reported homologous EST clones (GenBank TM accession number BB639234, Table I ). When this first exon is fused to exon 2, a 1648-nt intron (mI1c) that contains consensus GT-AG splice sites is spliced out. Sequencing of an RT-PCR-amplified DNA fragment confirmed the existence of mE1c in the mouse cortex.
An additional mRNA transcript that contains mE1c but proceeds through the genomic sequence was named mE1c-long. Two longer ESTs indeed initiated at mE1c (GenBank TM accession numbers BB629342, adult bone, and CA327701, whole brain embryo) and extend through the entire genomic sequence to exon 2 (GenBank TM accession number AK036443, adult male bone). In these ESTs, exon 2 is fused to exon 3. Splicing of intron 2 rules out the possibility of genomic DNA contamination as the source of this mE1c-long variant.
Further upstream, an alternative first exon (8) had previously been found at position Ϫ2271 to Ϫ1980 followed by a 1957-nt intron (mI1d). This first exon was found to be fused with exon 2. We confirmed the expression of the corresponding transcript in the prefrontal cortex by RT-PCR and sequencing. This exon was named mE1d. Two alternative splice donors that differ by 29 nucleotides were observed in the mouse cortex. We named the shorter form mE1dЈ (GenBank TM deposit, accession number AY389980).
Upstream from mE1d, three different putative ORFs (positions Ϫ2518 to Ϫ2402, Ϫ2925 to Ϫ2522, and Ϫ3129 to Ϫ2933) were found in a continuous reading frame with that of the classical protein. These could add 46, 142, or 73 amino acids (respectively) to the common ORF beginning at exon 2. Of these, the mE1e ORF shares 79% sequence similarity with the corresponding region in the human ACHE gene and its translated sequence (see below) and was thus regarded as a candidate. Fig. 1, A and B , depicts the different mouse 5Ј exons.
5Ј Diversity of Human AChE mRNAs-EST data base searches using the 5Ј region of the human (h) ACHE gene revealed the existence of at least four alternative first exons ( Table II) . The previously identified mouse EST clone (mE1a GenBank TM accession number BB606349, see above) suggests the existence of the alternative first exon named hE1a.
The known first exon at Ϫ1681 to Ϫ1576 (relative to the translational start site ATG present in the human exon 2) (11) is named here hE1b (represented by EST clone GenBank TM accession number BG707892, human brain hypothalamus). A 1543-nt intron (hI1b) separates hE1b from exon 2 (position Ϫ23). We confirmed the existence of hE1b by RT-PCR and sequencing.
An additional EST clone contained the genomic sequence located at position Ϫ1859 to Ϫ1824 (GenBank TM accession number BI667712, human brain hypothalamus). This putative first exon, fused to exon 2 at position Ϫ20 (ACG), was named hE1c. The corresponding 1803-nt intron (hI1c) includes donor and acceptor splice sites (GT-AG). Exon 2 starts with two optional acceptor splice sites located 3 nucleotides apart (both AG dinucleotide; Fig. 1, C and D) . Therefore, when fused to hE1c, exon 2 starts at a different position than the one described previously. Our attempts to confirm the existence of this transcript failed.
An additional EST clone (GenBank TM accession number BX420294, human fetal brain) contained a putative first exon located further upstream at position Ϫ2720 to Ϫ2318 (exon hE1d) fused to exon 2 at position Ϫ20. This implies the existence of a 2294-nt intron (hI1d). The existence of this mRNA was confirmed by RT-PCR and sequencing (GenBank TM deposit, accession number AY389977; Fig. 1 , C and D). Intriguingly hE1d harbors a translation start codon (ATG, position Ϫ2495) creating a continuous reading frame with that of the classical ATG in exon 2 (12), thus potentially adding 66 amino acids to the AChE protein. An additional ATG (position Ϫ2478) in the same ORF may yield a shorter 61-amino acid domain. Sequence homology with mE1e, which lacks the first ATG, suggests that the second ATG is more likely to serve as the translational start site.
Putative Promoters for the Novel Exons-Using luciferase assays, Atanasova et al. (8) demonstrated the functionality of the promoter located upstream to mE1d (referred to in their work as exon E1a). In our study, the Cister and Chip2Promoter programs enabled promoter predictions, which are shown in Fig. 2A for the murine and human ACHE genes. These programs search for regions with motif conservation predicting high probability of being transcriptionally active promoters. These are based primarily on the density of putative transcription factor binding sites. Several regions with such high probability were revealed by this search. Promoter prediction analyses of the region containing the novel alternative first exons revealed a plausible promoter for each of the newly identified exons of both the mouse and human genes (Fig. 2, A and B) . The probability score of the alternative promoters was found to be similar to that of the previously described promoter (upstream to mE1b in mouse and hE1b in human), supporting the notion that they might be functionally active. A particularly high probability to function as a promoter was observed for the mouse region upstream to exon mE1a. In the human gene, we identified hE1a based on homology to the mouse mE1a. Exon hE1a is a weak candidate for being a true exon because it lacks consensus splice sites and because no ESTs were found in the entire region between exon 2 and exon hE1b in the human sequence. Intriguingly the region located upstream from hE1a displays the highest probability of functioning as a promoter ( Fig. 2A) , perhaps suggesting a change in function for this sequence during evolution. The Cister and the Chip2Promoter program, which does not apply to murine sequences, yielded similar predictions for human promoters.
A closer look at the distribution of the transcription factor binding sites revealed that most sites are common to several of the putative alternative promoters and evolutionarily conserved in both human and mouse. Several putative DNA targets, however, were unique to one of the identified promoters. For example, a conserved binding site for the transcription factor Dlx, highly expressed during organ development (13) , was found in mP1 and hP1, and a putative binding site for transforming growth intestinal factor was found in mP2 and hP2. Of interest, three putative glucocorticoid response elements (GREs) were identified in the upstream region of the human ACHE gene (one in hP3 and one adjacent to hE1a, Fig.  2A ), and one was identified in the mouse gene (mP2, Fig. 2A ). It was therefore tempting to test the glucocorticoid and/or stress response of these newly identified transcripts.
Short Interspersed Nuclear Elements (SINEs) and Long Interspersed Nuclear Elements (LINEs) Separate 5Ј Alternative
Exons from the Distal Human ACHE Promoter-On average, one might expect one SINE and one LINE for approximately every 2-3.5 kb except within the transcription unit itself (14) . A totally different outcome emerged for the currently available GenBank TM ACHE sequences (20 kb of the human, GenBank TM accession number AF002993, and 9.5 kb of mouse, GenBank TM accession number AF312033) upstream to the translation start sites of exon 2. The SINE and LINE distributions were analyzed using the Eldorado software (Genomatix) and the RepeatMasker algorithm (Baylor College of Medicine Search Launcher). The density was found to be 6-fold higher than the expected average for SINEs and almost 2-fold higher than the expected average for LINEs (Fig. 2, C and D) . This leaves little room for any functional DNA in this area. In contrast, exceptionally few repeats (one and three, respectively) were found within the human and mouse 3.5-kb regions where the alternative first exons were identified, supporting a functional role for these DNA fragments in human and mouse. The closest gene upstream to ACHE is located ϳ180 kb away (15) .
Tissue Distribution of the Novel Exons in Mouse-Tissue distribution in mouse of the mRNAs containing the different alternative first exons was studied by RT-PCR (Fig. 3A) . Exon mE1a was found to be expressed in every examined brain region, including hippocampus, cortex, PFC, brainstem, and basal nuclei. Exon mE1a was also expressed in the thymus, heart, liver, intestine, and spleen but not in kidney, testis, muscle, or spinal cord. Exon mE1b was detected in most of the tissues examined with the exception of liver, intestine, and muscle. Exon mE1c was the most widely expressed. It was, however, absent from intestine. Exon mE1d was detected in the brain (hippocampus, PFC, brainstem, and basal nuclei) and heart but not spleen, thymus, intestine, or liver. While it is difficult to compare the expression levels between different
RT-PCR products due to differences in primer and target efficiency, a tissue distribution analysis, as was conducted, gives a good hint of the relative expression levels of each variant in each tissue. We conclude that mE1c is the most abundant transcript due to its almost ubiquitous expression and due to its over-representation by ESTs (Table I) .
For comparison, we investigated in the same tissues the expression profiles of the different AChE 3Ј variants. "Synaptic" AChE-S was strongly expressed in all tissues examined except for thymus, liver, and the small intestine where only weak expression was observed, similar to the expression pattern of mE1c. "Read-through" AChE-R was strongly expressed in all of the brain regions tested and in spleen. It was moderately expressed in heart, muscle, kidney, spinal cord, and liver and very poorly expressed in the testis, thymus, and intestine.
"Erythrocytic" AChE-E was expressed in all of the examined brain regions as well as in heart, kidney, spinal cord, liver, spleen, and muscle. It was absent from testis, thymus, and the small intestine. Thus, none of the 5Ј variants shared the same expression pattern with a single 3Ј variant, suggesting that 5Ј splicing patterns do not always dictate 3Ј splicing in the mature mRNA. The four different 5Ј and three different 3Ј splice options may thus potentially yield 12 distinct transcripts.
Distinct Neuronal Distributions of the 5Ј Murine Exons-To achieve cellular resolution levels for the expression patterns of the novel exons, we designed 40 -50-mer 5Ј-biotinylated fully 2Ј-O-methylated riboprobes for FISH (see "Experimental Pro- cedures" for details). Fig. 3B presents representative FISH  profiles for mE1a, mE1b, and mE1d .
These three exons all appeared to be expressed in neurons. They displayed, however, distinct cell type specificities and subcellular distributions. For example, essentially all of the deep layer neurons in the PFC displayed pronounced mE1a levels and considerably lower mE1b labeling. Exon mE1d mRNA was particularly concentrated in the uppermost layer of PFC neurons (Fig. 3B, I ), suggesting distinct levels for AChE mRNA transcripts in specific subsets of PFC neurons. Whereas these differences potentially reflect probe efficiencies, they also highlight distinct expression patterns for the various alternative AChE mRNAs. Thus, hippocampal CA2 neurons within the same or adjacent sections displayed consistently low levels of all three exons (Fig. 3B, II) , whereas cerebellar neurons showed differential expression of the various 5Ј exons (Fig. 3B,  III) . Exon mE1a accumulated in the cytoplasm of Purkinje cell perikarya but was only faintly detected in other cerebellar neurons. mE1b was poorly expressed in the cerebellum, and mE1d was strongly expressed in Purkinje cells in which it was labeled in both cell bodies and axonal processes (Fig. 3B , IV and V). In addition, mE1d was transcribed in other neurons of the cerebellum, including the cells interspersed in the molecular layer. In these neurons, it displayed an asymmetric labeling pattern accompanied by neurite labeling. Granular neurons were poorly labeled with the probe for mE1d.
Human hE1d AChE mRNA Expression-The tissue distribution of transcribed hE1d mRNA in several developmental stages was explored in paraffin sections from human embryos aged 16, 25, and 34 weeks. At week 16, hE1d mRNA was only weakly detected in the nervous system and was absent in the thymus. As development proceeded, hE1d expression became more pronounced with increased density of positive cells and increased labeling intensity in both the nervous system and the thymus. At week 34, up to 50 Ϯ 10% of the neurons were positive (Fig. 4A) . In contrast, as low as 2 Ϯ 1.5% of the thymus cells were hE1d mRNA-positive at week 25, but by week 34, over 8 Ϯ 1.5% of the cells were positive (p Ͻ 0.0005, two-tailed Student's t test). Since hE1d demonstrated a developmentally regulated expression pattern, we performed RT-PCR analysis on RNA extracted from human embryonic stem cells (16) and leukemic T-cell lymphocytes. Whereas human embryonic stem cells were RT-PCR negative for hE1d, leukemic T-cells were positive (Fig. 4B) .
The developmentally regulated expression of hE1d mRNA in the fetal thymus and in T-cells called for corresponding analysis of its putative translation product, hN-AChE. Rabbit polyclonal antibodies were generated against two short internal peptides from the hN-AChE ORF (Fig. 4B) . Although unsatisfactory for immunohistochemistry on paraffin-embedded sections, these anti-hN-AChE antibodies successfully labeled human mononuclear cells in flow cytometry analysis. Cord blood cell lineages were classified according to their relative side scatter and their expression levels of the blood cell marker CD45 into lymphocytes (Fig. 4E, L) , monocytes (M), granulocytes (G), blood cell progenitors (P), and nucleated erythrocytes (NE). Monocytes and granulocytes, both of which express AChE (40) , displayed the most prominent hN-AChE labeling with 67 Ϯ 19 and 57 Ϯ 21% of the cells expressing hN-AChE as compared with isotype control. In addition, 17 Ϯ 7% of the lymphocytes and 7.5 Ϯ 4% of the progenitors were hN-AChEpositive (Fig. 4, D and E) , while nucleated erythrocytes were negative. To further subclassify the lymphocytes expressing hN-AChE, we used specific markers for undifferentiated cells (CD34), early T-cells (interleukin 7), mature T-cells (CD3), and mature B-cells (CD19). Some of these markers may appear in more than one cell lineage; however, hN-AChE labeling appeared in 9 Ϯ 3 and 10 Ϯ 3% of the CD34 ϩ undifferentiated cells and early T-cells and increased to 14 Ϯ 9% in mature T-cells. B-cells presented highly variable (7.5 Ϯ 6.5%) hNAChE labeling.
To test whether hN-AChE is membranal, as predicted from its primary structure analysis, the flow cytometry tests were repeated following permeabilization of the cells. Following permeabilization, monocyte and granulocyte labeling decreased to 7 ؎ 1 and 20 ؎ 7.5%, respectively, implying that hN-AChE is mainly present at the membrane. (17) yet long lasting (6) expression of AChE-R mRNA encoding an AChE variant with a cysteinefree C terminus, which leads to the accumulation of stressassociated AChE monomers. The ACHE gene possesses a GRE in a distal enhancer (18) , and ACHE gene expression increases following administration of the murine stress hormone corticosterone (6). We therefore investigated whether any of the novel 5Ј exons are selectively overproduced following stress in control mice as compared with mutant mice that selectively lack the GR gene in their central nervous system (GR NesCre mice (9)).
Stress-and Glucocorticoid-associated Expression of the Novel Exons-Stress induces rapid
In the mouse PFC, mE1b mRNA levels were largely unaltered in the GR NesCre control littermates. However, when the mutant animals were stressed by immobilization, mE1b mRNA decreased significantly within 2 h in GR NesCre mice as compared with either unstressed GR NesCre mice or with stressed control mice (Fig. 5) , implying a role for the GR in maintaining normal levels of mE1b following stress. In contrast, mE1c mRNA levels increased similarly in stressed control and GR NesCre animals. This suggests that the expression of the mE1c exon is upregulated in response to immobilization stress in a manner that does not involve the GR transcription factor. Mouse mE1d, however, was markedly up-regulated 2 h after immobilization stress in control mice but only very slightly in GR NesCre mutant mice. This suggests massive stress-induced and glucocorticoiddependent regulation of mE1d. AChE-S mRNA remained generally unchanged in stressed wild type mice, compatible with our previous findings (6, 17) . In contrast, AChE-S mRNA levels decreased substantially in stressed mutant mice, suggesting that the 3Ј alternative splicing pattern of AChE pre-mRNA is glucocorticoid-dependent. Thus, while actin mRNA levels remained unchanged, each of the analyzed variant exons displayed a unique combination of stress and glucocorticoid responses.
FIG. 6. N-AChE protein.
A, DNA sequence homology between mE1e (top) and hE1d (bottom). Total similarity is 79%. The in-frame ATGs are colored. B, amino acid sequence of mN-AChE (mE1e) (top) and hN-AChE (hE1d) (bottom). Boxes, lines, and red and blue backgrounds note identical, related, and hydrophobic and positively charged amino acid residues (arginine and lysine, dark blue; histidine, light blue). Putative phosphorylation sites are green; putative N-myristoylation sites are dark yellow (GENESTREAM, vega.igh.cnrs.fr/bin/align-guess.cgi) The last methionine is the translation start site on exon 2. Secondary structure prediction (GOR4 software, see Footnote 4) is depicted above and below each sequence (c, random coil; e, extended strand; h, ␣ helix). Note the lack of ␣ helices and ␤ sheets of hN-AChE. C, expression in human brain regions. Inset, top left, extracts of cultured human glioblastoma cells. Note similarity of labeling patterns for anti-hN-AChE and anti-core-AChE antibody (N19, Santa Cruz Biotechnology). Center, hN-AChE in different human brain regions. Note prominent hN-AChE expression in the occipital cortex (oxc) and significant labeling in hippocampus (hipp), PFC, cortex, striatum (str), and amygdala (amg). Very weak bands were observed in the cerebellum (cer). D, FISH. hE1d mRNA probe labels both cell bodies and neurites of neurons in adult human PFC. E, locations of the different brain regions tested.
N-AChE Protein Products-Novel 5Ј extended putative ORFs, in-frame with the known AChE coding sequences, were identified in orthologous regions of the mouse mE1e and the human hE1d exons. The putative ORF of mE1e encodes an additional 46 amino acids with no homology to any known protein in the data base (Fig. 6A) . These include 8 positively charged residues (4 arginines, 1 lysine, and 3 histidines) but only 2 negatively charged ones (2 glutamates), yielding an extremely high pI value of 11.54. Secondary structure analysis of the mE1e translation product (mN-AChE) (GOR4 software) 4 revealed a potential ␣ helical folding (Fig. 6B, top) . Motif Scan software analysis 5 revealed in this peptide a putative protein kinase phosphorylation site (position 4 -6, TsR) and an Nmyristoylation site (position 13-18, GGhrSG, Fig. 6B ). An addition of this peptide chain to the N terminus will most likely prevent cleavage of the mouse AChE signal peptide (MRPPW-YPLHTPSLAFPLLFLLLSLLGGGARA, position 1-31). This will yield a 77 (46 ϩ 31)-amino acid residue extension of the mN-AChE protein (13.4% increase over the 574 residues of mAChE-S (19)) with the signal peptide predicted to become transmembranal (e.g. the asialoglycoprotein receptor variant (20) ).
The corresponding human exon hE1d encodes an N-terminal extension of 66 amino acids in-frame with the hAChE protein (Fig. 6B ). This peptide as well precedes the signal peptide (MRPPQCLLHTPSLASPLLLLLLWLLGGGVGA, position 1-31) that is normally cleaved off during maturation. We predicted its presence to prevent AChE cleavage, resulting in a larger protein (by 92 (61 ϩ 31) or 97 (66 ϩ 31) amino acids, 16 -17% increase over the 574 residues of AChE-S (12)).
No significant homology was found for the hN-AChE peptide sequence in the Swiss-Prot data base. Similar to mN-AChE, the human peptide includes a putative phosphorylation site (for casein kinase II, position 7-10, ScpD) as well as an N-myristoylation site (position 31-36, GGsrSF, Fig. 6A ). In addition, similar to mN-AChE, hN-AChE displays an extremely high predicted pI (11.76), matching that of histones and other nucleic acid-binding proteins. 6 In immunoblots of glioblastoma protein extracts, the polyclonal anti-hN-AChE antibodies labeled an ϳ66 -70-kDa double band comparable to the labeling pattern observed using the commercially available N19 anti-AChE antibody (Fig. 6C, inset, top left) . Protein extracts from different regions of the human brain (shown schematically in Fig. 6E ) demonstrated a similar size for the hN-AChE protein in vivo (Fig. 6C, bottom) . Expression spanned various cortical domains, including PFC and the occipital cortex where it was most prominent. The hippocampus, striatum, and amygdala were also positive, but cerebellar expression was very low. To achieve better resolution, we turned to mRNA in situ hybridization. FISH analysis of paraffin-embedded human PFC sections revealed prominent neuronal hE1d mRNA labeling with 57 Ϯ 34% of the cells in the PFC being positive. Up to 25% of the labeled cells displayed hE1d mRNA labeling in neuritic processes, reaching 14.5 Ϯ 7.5 m in length (Fig. 6D) . A significant fraction of the stressresponding PFC neurons thus express hN-AChE both in their cell body and in neurites.
DISCUSSION
The recent availability of human and mouse genomic sequences together with rich EST data bases and advanced computer programs enabled the identification of novel alternative 5Ј exons and corresponding promoters in the human and mouse ACHE genes. Two proximal human (18) and mouse (7, 8 ) ACHE promoters have been described previously. In our current study we demonstrate that human and mouse ACHE genes contain at least four alternative first exons each of which at least one encodes an extended N terminus. We named the extended AChE protein(s) hN-AChE and found expression of this protein(s) in the nervous system and blood cells during various stages of their development.
Alternative Splicing and Alternative Promoter Usage in AChE-Alternative splicing enables the creation of different mRNAs and different proteins from a single gene, thus increasing the diversity of gene expression and the proteome (1). AChE is expressed in a large variety of non-cholinergic, non-cholinoceptive tissues and generates at least three different proteins with distinct C termini produced by alternative splicing. These likely differ in their non-catalytic activities, independent of the acetylcholine-hydrolyzing capacity of AChE (21) . An additional level of diversity is enabled by the different alternative first exons, suggesting a combinatorial complexity.
The alternative first AChE exons display expression profiles distinct from those of the 3Ј exons. This rules out the possibility that a particular first exon is strictly associated with a given 3Ј exon. The 3Ј splicing options of the murine and human AChEs (AChE-S, AChE-R, and AChE-E) may thus yield up to 15 and 12 different mRNA transcripts, respectively (Fig. 7) . Diversified regulation at the 5Ј-untranslated region level may reflect yet unexplained roles for the 5Ј variants. For example, in the human fetus, hE1d mRNA was expressed in the nervous system and thymus in a developmentally regulated manner. In the fetal brain, hE1d mRNA was expressed in migrating neurons in both cell bodies and neuritic processes, and the number of hE1d-positive neurons grew from roughly undetected levels at week 16 to about 50% of the neurons at week 34, coinciding with the formation of synapses in these neurons. Further studies will be required to find whether this coincidence reflects a functional relationship.
N-terminally Extended N-AChE(s)-Of particular interest are the novel N-AChE protein(s) containing N-terminal extensions. The extended translation products displayed 79% sequence similarity in human and mouse with similarly high pI values and similar phosphorylation and N-myristoylation sites of the putative translation products, supporting the notion of physiological relevance. The classical human AChE protein includes a 31-amino acid residue signal peptide at its N terminus that is cleaved off during protein maturation. However, we predicted that adding hE1d to the AChE mRNA transcript and its translation product to the AChE protein would prevent the cleavage of this signal peptide. Under these conditions, the corresponding region in the AChE translation product would become a transmembrane domain in an N-terminally extended (and 16% larger) AChE variant (hN-AChE). Analogous situations have been described for the asialoglycoprotein receptor (20) , adrenal dopamine ␤-monooxygenase (22), ␣-neurexin (an extended form of ␤-neurexin) (23), retinal RodX exchanger (24) , prion protein (25) , and cyclooxygenase (26) . COX-1, the classic cyclooxygenase form, includes a signal peptide at the N terminus. A novel cyclooxygenase variant, COX-3, includes an unusually spliced nucleotidic sequence, which encodes for an Nterminal extension of the protein. This prevents the cleavage of the signal peptide, resulting in a transmembrane protein variant with distinct properties.
Membrane Properties of N-AChE-Antibodies generated against the hN-AChE peptide interacted with at least two brain-expressed polypeptides with electrophoretic properties similar to those of AChE, and several of the commercially available anti-AChE antibodies yield double bands around 66 -70 kDa (for example, see Refs. [27] [28] [29] . This supports the notion that at least part of the brain AChE proteins corresponds to N-terminal extended form(s). The N terminus of hN-AChE may enable monomeric AChE-S or AChE-R to traverse the membrane, conferring yet undefined physiological functions onto its cytoplasmic domain (Fig. 7) . As a matter of fact, initial studies by Podleski and Changeux (30) suggested receptor-like function for membrane AChE (30) . Direct docking of AChE to the synaptic membrane would explain its presence in brain regions lacking the proline-rich membrane anchor (PRiMA) subunit necessary to anchor AChE-S tetramers to the synapse (31, 32) . This could have an especially significant outcome for poststress situations where large amounts of monomeric AChE are produced rapidly. Membrane targeting of the produced enzyme could be efficient for rapidly reducing the synaptic levels of acetylcholine, whereas its putative N-terminal phosphorylation and myristoylation can possibly transduce cytoplasmic signals.
Flow cytometry analyses demonstrated that, in blood cells, hN-AChE is primarily located in membranes. Monocytes, granulocytes, and lymphocytes were all positive albeit to different extents. In lymphocytes, hN-AChE levels increased from early to mature T-lymphocytes, possibly explaining the distinct expression patterns throughout thymic development. Indeed hE1d mRNA was expressed in RNA extracted from human leukemic T-cells but not from human embryonic stem cells. hN-AChE expression in T-and B-lymphocytes is compatible with reports of cholinergic regulation of lymphocyte function (33) . Moreover exposure to anti-AChEs, which induce AChE overexpression (21), also involves an increased risk of leukemia (40) . Our current findings point at N-AChE as a putative candidate in that process.
Electrostatic as well as covalent interactions of hN-AChE monomers having diverse C termini (e.g. AChE-E and AChE-S) can potentially create hN-AChE-associated multimers with complex structures. Unusual AChE forms have been reported in Alzheimer's disease (34, 35) and in dementia (36) . Sucrose gradient analyses also reveal high diversity of the various AChE isoforms (37) . Much of these observations could reflect these new, longer members of the AChE family, and the potent labeling of brain AChE-like proteins with anti-hN-AChE antibodies suggests multiregional abundance of such variants.
Density of Repeats-Alu repeats are the most abundant SINEs within the primate genome (14) . In humans, 1.5 million SINEs account for some 13% of the genome, and the 850,000 LINEs account for another 21%, comprising together a grand total of 34% of the genome (38) . LINEs are usually found in gene-poor, AT-rich areas; SINEs are preferentially located within gene-rich regions. During evolution, LINEs and SINEs replicate and/or move about the genome. Residing at or near transcriptionally active regions increases the rate of such events, while interference with transcription can be deleterious (14) . These opposing forces lead to the accumulation of repeats near to, but not inside, transcriptionally active sites. The human and mouse ACHE genes demonstrated an inverse association between the repeat density in transcribed units as compared with 5Ј upstream sequences, compatible with parallel findings in most functional transcription units (14) . Since ACHE is a ubiquitously active gene, such accumulation of repeats is not surprising. The absence of repeats from the 3.5-kb exon-containing region, in view of the dense repeat population in this locus, further supports the notion that the novel first exons are functionally active and carry out evolutionarily advantageous roles. Differential Expression Patterns-Alternative first exons could influence the cellular and subcellular distribution of the different transcripts. In brain neurons, AChE mRNA is subject to stress-related regulation and neuritic translocation (6) . Stress-responding neurons display replacement of dendritic AChE-S with AChE-R mRNA, and it remains to be tested which of the newly identified first exons are similarly regulated. None of the three 5Ј murine probes tested (mE1a, mE1b, and mE1d) showed dendritic expression in control mice, but in murine Purkinje cells, mE1d presented an unusual subcellular expression in both cell bodies and axons. Axonally deposited mRNA transcripts are known albeit rare (39) . This observation poses novel questions regarding the expression pattern and the physiological function of AChE in Purkinje cells in general and in axonal processes in particular.
Expression in Response to Stress-We wished to find out whether the newly described transcripts are differentially regulated under stress and, if so, whether the stress-induced release of GCs is involved. Various putative DNA binding elements that could be involved in induction of ACHE expression, including GRE, AP1, and cAMP-response element-binding protein, are present in the different promoter regions. One GRE site was identified within mE1d, and two were identified upstream to mE1b. AP1 sites were found in mP2 and mP3. We therefore studied the expression of the different AChE mRNA variants in response to immobilization stress both in control (GR LoxP/LoxP ) and in mice deprived of GR in neurons and glial cells (GR NesCre mice (9)). Two different variants, mE1c and mE1d, were found to be induced in response to stress. Of these two, mE1d but not mE1c requires the activation of GR for its induction. In contrast, both mE1b and AChE-S were repressed under stress but only in GR NesCre mice. One possible explanation could be that following stress, contrasting effects of different factors, among them glucocorticoids, cancel out one another, keeping the levels of mE1b unaltered. In the absence of GRs, the GREs are no longer functional, and maintained activities of suppressing factors may then reduce mE1b levels.
In conclusion, the existence of novel 5Ј alternative splicing patterns of AChE mRNA has important consequences. First and foremost, they extend the complexity and versatility of AChE mRNA variants to levels that were not previously perceived. In addition, the 5Ј splice variations yield N-terminally extended membrane variant(s) of AChE in brain neurons and hematopoietic cells. While the C-terminal composition and membrane directionality of these variants await further research, this finding explains certain long known enigmas in AChE research and opens numerous new questions. The apparent conservation of this extended domain in rodents and primates strengthens its biological relevance. Its unique expression patterns and stress-associated regulation call for exploring its physiological significance.
